GLP-2 (T) Tirzepatide (15mg)

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It activates both incretin receptors simultaneously, enhancing insulin secretion, reducing glucagon levels, and promoting satiety through complementary mechanisms. This dual-agonist approach represents an advanced strategy in metabolic peptide research. It is classified under the Metabolic Peptides research category and is studied in the following areas: Metabolic Health, Weight Management, Insulin Sensitivity, Dual Incretin.

Our GLP-2 (T) Tirzepatide (15mg) is tested at 99%+ purity via third-party HPLC analysis. Every order ships with a Certificate of Analysis (COA) documenting purity, identity, and endotoxin levels.

GLP-2 (T) Tirzepatide (15mg) should be stored at -20°C. It is supplied as a lyophilized powder and is soluble in bacteriostatic water.

Dual GIP/GLP-1 receptor agonist; activates both incretin receptors to enhance insulin secretion, reduce glucagon, slow gastric emptying, and increase satiety through complementary pathways

GLP-2 (T) Tirzepatide (15mg) has a molecular weight of 4813.45 g/mol. Its amino acid sequence is: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.

Yes. Every batch of GLP-2 (T) Tirzepatide (15mg) is third-party tested and ships with a full Certificate of Analysis (COA) documenting HPLC purity, mass spectrometry identity confirmation, and endotoxin testing results.

~5 days

In published research, GLP-2 (T) Tirzepatide (15mg) has been administered via subcutaneous injection. All use is for laboratory research purposes only.